For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250527:nRSa2857Ka&default-theme=true
RNS Number : 2857K Integrated Diagnostics Holdings PLC 27 May 2025
Integrated Diagnostics Holdings plc
(the "Company")
Result of Annual General Meeting
27 May 2025
The Company announces that at the Annual General Meeting ("AGM") held today at
the offices of Actis, 2 More London Riverside, London, SE1 2JT, all
resolutions contained in the notice of the meeting, including two special
resolutions were duly passed. The special resolutions authorise the Company
to allot shares on a non-pre-emptive basis and to make market purchases of
Equity Securities in the capital of the Company. Each of the resolutions put
to the AGM was voted on by way of a poll. The results of the poll for each
resolution were as follows:
VOTES FOR % VOTES AGAINST % VOTES WITHHELD TOTAL SHARES VOTED
1. To receive and consider the Company's Audited Financial Statements, 501,768,612 93.67 33,927,550 6.33 225 535,696,387
together with the Reports of the Directors and the Auditor for the year ended
31 December 2024.
2. To re-elect Lord Anthony Tudor St John as a Director. 446,661,983 86.48 69,813,211 13.52 19,221,193 535,696,387
3. To re-elect Dr. Hend El-Sherbini as a Director. 484,973,873 93.9 31,501,321 6.1 19,221,193 535,696,387
4. To re-elect Sherif El Zeiny as a Director. 458,400,726 88.76 58,074,468 11.24 19,221,193 535,696,387
5. To re-elect Richard Henry Phillips as a Director. 446,661,983 86.48 69,813,211 13.52 19,221,193 535,696,387
6. To re-elect ~Dan Johan Wilmar Olsson as a Director. 440,599,372 87.29 64,137,079 12.71 30,959,936 535,696,387
7. To re-elect Hussein Hassan Choucri as a Director. 440,594,372 87.29 64,142,079 12.71 30,959,936 535,696,387
8. To re-elect Yvonne Stillhart as a Director. 473,235,130 93.76 31,501,321 6.24 30,959,936 535,696,387
9. To re-appoint PwC LLP as Auditor to hold office from the conclusion of this 535,691,162 100 0 0 5,225 535,696,387
meeting until the conclusion of the next annual general meeting at which
accounts are laid before the Company.
10. To authorise the Directors to determine the Auditor's remuneration. 516,475,194 100 0 0 19,221,193 535,696,387
11. Authority to issue and allot shares. 463,197,812 89.68 53,277,382 10.32 19,221,193 535,696,387
12. To hold shares as Treasury Shares. 484,971,300 93.9 31,503,894 6.1 19,221,193 535,696,387
13. To execute ancillary documents. 484,971,300 93.9 31,503,894 6.1 19,221,193 535,696,387
14. To authorise the Directors to dis-apply statutory pre-emption rights. 463,967,865 89.83 52,506,670 10.17 19,221,852 535,696,387
15. Authority for the Company to make market purchases of its own shares. 516,466,962 99.99 7,573 0.01 19,221,852 535,696,387
Further information on the resolutions and the voting report will be available
on the Company's website at https://investors.idhcorp.com/
(https://investors.idhcorp.com/) .
Copies of the resolutions passed as special resolutions at the AGM will
shortly be available for inspection at the National Storage Mechanism, which
is located at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .
-Ends-
For further information please contact:
Integrated Diagnostics Holdings plc
Tarek Yehia tarek.yehia@idhcorp.com (mailto:tarek.yehia@idhcorp.com)
Investor Relations Director
Company Secretary IDHLondon@c (mailto:IDHLondon@cm.mpms.mufg.com) m.mpms.mufg.com
(mailto:IDHLondon@cm.mpms.mufg.com)
MUFG Corporate Governance Limited
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RAGSESFIWEISELI